TWiV 1010: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses the CDC HIV surveillance report, FDA voted in favor of approving the Abrysvo vaccine, canine olfactory detection of SARS-CoV-2-infected humans, safety of the BNT162b2 COVID-19 vaccine in children aged 5 to 17 years, and statement on the antigen composition of COVID-19 vaccines. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode HIV surveillance report (CDC) FDA voted in favor of approving Abrysvo vaccine (Pfizer) Canine olfactory detection of SARS-CoV-2-infected humans (Annals of Epidemiology) Safety of the BNT162b2 COVID-19 vaccine in children (JAMA) Statement on the antigen composition of COVID-19 vaccines (WHO) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1010 Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]